Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | EXEL | PCVX | ||
| Company | Cytokinetics | Exelixis Inc | Vaxcyte Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 65.00 | 23.50 | 60.32 | ||
| High | 66.12 | 23.75 | 60.94 | ||
| Low | 64.50 | 23.36 | 59.41 | ||
| Last | 65.34 | 23.70 | 60.72 | ||
| Change | +0.54 | +0.17 | +0.66 | ||
| % Change | +0.83% | +0.72% | +1.10% | ||
| Volume | 738,000 | 1,560,800 | 594,300 | ||
| 20-Day Average Volume | 1,046,700 | 1,921,225 | 720,040 | ||
| Previous Close | 64.80 | 23.53 | 60.06 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 69.67 | 23.20 | 62.68 | ||
| 20-Day Raw Stochastic | 12.19% | 85.22% | 26.20% | ||
| 20-Day Relative Strength | 42.94% | 57.43% | 39.79% | ||
| Weighted Alpha | +8.18 | +27.67 | +33.15 | ||
| Today's Opinion | 24% Buy | 100% Buy | 8% Buy | ||
| Previous Opinion | 24% Buy | 96% Buy | 8% Sell | ||
| Last Month's Opinion | 56% Buy | 88% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.27% since 04/19/24 | +5.24% since 04/19/24 | -0.18% since 04/19/24 | ||
| Low | 63.90 on 04/25/24 | 22.59 on 04/22/24 | 58.10 on 04/25/24 | ||
| High | 68.76 on 04/23/24 | 23.78 on 04/24/24 | 63.22 on 04/22/24 | ||
| 1-Month | |||||
| %Chg | -8.17% since 03/26/24 | +0.38% since 03/26/24 | -9.94% since 03/26/24 | ||
| Low | 63.90 on 04/25/24 | 22.23 on 04/19/24 | 58.10 on 04/25/24 | ||
| High | 75.71 on 04/09/24 | 23.98 on 03/28/24 | 69.68 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | -21.03% since 01/26/24 | +7.14% since 01/26/24 | -5.58% since 01/26/24 | ||
| Low | 61.33 on 03/14/24 | 20.01 on 02/12/24 | 58.10 on 04/25/24 | ||
| High | 84.05 on 02/02/24 | 24.07 on 03/21/24 | 82.04 on 02/28/24 | ||
| 6-Month | |||||
| %Chg | +101.60% since 10/26/23 | +12.91% since 10/26/23 | +25.79% since 10/26/23 | ||
| Low | 30.37 on 10/27/23 | 19.20 on 01/08/24 | 46.16 on 11/13/23 | ||
| High | 110.25 on 01/08/24 | 24.34 on 01/02/24 | 82.04 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,832,995 | 6,986,760 | 6,603,847 | ||
| Shares Outstanding, K | 104,576 | 294,800 | 108,759 | ||
| Annual Sales | 7,530,000 | 1,830,210,000 | 0 | ||
| Annual Net Income | -526,240,000 | 207,770,000 | -402,270,000 | ||
| Last Quarter Sales | 1,670,000 | 479,650,000 | 0 | ||
| Last Quarter Net Income | -136,900,000 | 85,520,000 | -180,800,000 | ||
| 60-Month Beta | 0.68 | 0.54 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.38 on 02/27/24 | 0.33 on 02/06/24 | -1.82 on 02/27/24 | ||
| Latest Earnings Date | 05/08/24 | 04/30/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.77 | 0.00 | ||